Bellevue HEALTHCARE TRUST plc
LEI: 213800HQ3J3H9YF2UI82
30 March 2022
Director/PDMR Shareholding
Bellevue Healthcare Trust Plc announces that the below ordinary redeemable shares have been acquired from the net directors' fees payable for the quarter ended 31 March 2022:
Director |
Number of Shares purchased |
J Dixon |
3,190 |
R Grewal |
5,443 |
P Southgate |
2,212 |
T Young |
2,471 |
K Bolsover |
2,471 |
Following these transactions, the above directors' total shareholdings in the Company are as follows:
Director |
Total shareholding |
J Dixon |
90,170 |
R Grewal |
106,776 |
P Southgate |
77,034 |
T Young |
13,968 |
K Bolsover |
7,577 |
Enquiries:
Sanne Fund Services (UK) Limited |
+44 20 3327 9720 |
Company Secretary |
|
|
|
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Josephine Dixon |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Bellevue Healthcare Trust Plc |
||||
b)
|
LEI
|
213800HQ3J3H9YF2UI82 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Redeemable Ordinary Shares |
||||
|
|
|||||
Identification code |
|
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Purchase |
||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
182.5759p per share |
3,190 |
|
||
|
|
|
|
|
||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
3,190 |
|||||
|
|
|||||
- Price |
Total price £5,824.17 |
|||||
|
|
|||||
e)
|
Date of the transaction
|
29 March 2022 |
||||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Randeep Grewal |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Bellevue Healthcare Trust Plc |
||||
b)
|
LEI
|
213800HQ3J3H9YF2UI82 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Redeemable Ordinary Shares |
||||
|
|
|||||
Identification code |
|
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Purchase |
||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
182.5759p per share |
5,443 |
|
||
|
|
|
|
|
||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
5,443 |
|||||
|
|
|||||
- Price |
Total price £9,937.61 |
|||||
|
|
|||||
e)
|
Date of the transaction
|
29 March 2022 |
||||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Paul Southgate |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Bellevue Healthcare Trust Plc |
||||
b)
|
LEI
|
213800HQ3J3H9YF2UI82 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Redeemable Ordinary Shares |
||||
|
|
|||||
Identification code |
|
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Purchase |
||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
182.5759p per share |
2,212 |
|
||
|
|
|
|
|
||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
2,212 |
|||||
|
|
|||||
- Price |
Total price £4,038.58 |
|||||
|
|
|||||
e)
|
Date of the transaction
|
29 March 2022 |
||||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Tony Young |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Bellevue Healthcare Trust Plc |
||||
b)
|
LEI
|
213800HQ3J3H9YF2UI82 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Redeemable Ordinary Shares |
||||
|
|
|||||
Identification code |
|
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Purchase |
||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
182.5759p per share |
2,471 |
|
||
|
|
|
|
|
||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
2,471 |
|||||
|
|
|||||
- Price |
Total price £4,511.45 |
|||||
|
|
|||||
e)
|
Date of the transaction
|
29 March 2022 |
||||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Kate Bolsover |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Bellevue Healthcare Trust Plc |
||||
b)
|
LEI
|
213800HQ3J3H9YF2UI82 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Redeemable Ordinary Shares |
||||
|
|
|||||
Identification code |
|
|||||
|
|
|||||
b)
|
Nature of the transaction
|
Purchase |
||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
182.5759p per share |
2,471 |
|
||
|
|
|
|
|
||
d)
|
Aggregated information |
|
||||
|
|
|||||
- Aggregated volume |
2,471 |
|||||
|
|
|||||
- Price |
Total price £4,511.45 |
|||||
|
|
|||||
e)
|
Date of the transaction
|
29 March 2022 |
||||
f)
|
Place of the transaction
|
London Stock Exchange |
END